USPTO serial 76586055
THROMBOSIS RESEARCH INSTITUTE
Reviewed by CopyMark Law Group
Reg. 2988319Status 710
- Filing date
- Status date
- Registration date
- Aug 23, 2005
- Examiner
- HAYES, GINA CLARK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with THROMBOSIS RESEARCH INSTITUTE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
The Thrombosis Research Institute
Chelsea, London SW3 6LR, GB
The Thrombosis Research Institute
Chelsea, London SW3 6LR, GB
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 016 | PUBLICATIONS AND DOCUMENTS, NAMELY, PAMPHLETS, BOOKLETS, PRINTED LECTURES, SCIENTIFIC REPORTS AND NEWSLETTERS, IN THE FIELDS OF BIOLOGY, VASCULAR BIOLOGY, COAGULATION, ANTICOAGULANTS, FIBRINOLYSIS, CYTOLOGY, CELL CULTURE, PROTEINS, PROTEIN BIOCHEMISTRY AND/OR PROTEOLYSIS, VASCULAR DISORDERS, THROMBOTIC DISORDERS, ARTHEROSCLEROSIS, HAEMOSTASIS, HYPERCOAGULABILITY, PHARMACEUTICALS, CANDIDATE PHARMACEUTICAL PRODUCTS, MEDICINE, MOLECULAR BIOLOGY, CHEMISTRY AND DISEASE | SECTION 8 - CANCELLED | — |
| 041 | EDUCATIONAL SERVICES, NAMELY PROVIDING AND CONDUCTING PROGRAMS, TRAINING, TEACHING, LECTURING, AND ARRANGING AND/OR CONDUCTING OF COLLOQUIUMS, SEMINARS, SYMPOSIUMS AND/OR WORKSHOPS, ALL IN THE FIELDS OF BIOLOGY, MEDICINE, PHARMACEUTICALS, THROMBOSIS AND ATHEROSCLEROSIS AND/OR THE BIOLOGY OR TREATMENT THEREOF; PROVISION OF INFORMATION RELATING TO BIOLOGY, MEDICINE, PHARMACEUTICALS, THROMBOSIS AND ATHEROSCLEROSIS AND/OR THE BIOLOGY OR TREATMENT THEREOF | SECTION 8 - CANCELLED | — |
| 042 | MEDICAL RESEARCH; SCIENTIFIC RESEARCH; MEDICAL AND SCIENTIFIC RESEARCH IN THE FIELD OF BIOLOGY, MEDICINE, PHARMACEUTICALS, VASCULAR BIOLOGY, COAGULATION, ANTICOAGULANTS, FIBRINOLYSIS, CYTOLOGY, CELL CULTURE, PROTEINS, PROTEIN BIOCHEMISTRY, PROTEOLYSIS, THROMBOSIS, ATHEROSCLEROSIS, AND/OR THE BIOLOGY OR TREATMENT THEREOF; RESEARCH AND DEVELOPMENT SERVICES TO FIND AND DEVELOP NEW PHARMACEUTICAL PRODUCTS FOR OTHERS TO PUT ON THE MARKET; THE PROVISION OF REPORTS AND INFORMATION RELATING TO CHEMICALS, BIOLOGICAL PRODUCTS, THE PREPARATION OF EITHER, FORMULATIONS, CANDIDATE PHARMACEUTICAL PRODUCTS, PHARMACEUTICAL RESEARCH PROJECTS, PHARMACEUTICAL RESEARCH SERVICES, MEDICINE, CHEMISTRY, MOLECULAR BIOLOGY, AND DISEASE; ARRANGING INVESTIGATIONS AND RESEARCH IN THE FIELD OF PHARMACEUTICALS TO OBTAIN INFORMATION AND DATA, TO BE SUPPLIED TO OTHERS, RELATING TO DRUGS, FORMULATIONS AND CANDIDATE PHARMACEUTICAL PRODUCTS; PHARMACEUTICAL DRUG DEVELOPMENT SERVICES; ARRANGING AND CONDUCTING MEDICAL AND SCIENTIFIC RESEARCH; PREPARING OR ARRANGING THE PREPARATION OF CHEMICALS, BIOLOGICAL PRODUCTS, FORMULATIONS AND/OR CANDIDATE PHARMACEUTICAL PRODUCTS FOR RESEARCH AND TESTING BY OTHERS; PROVIDING INFORMATION IN THE FIELD OF BIOLOGY, MEDICINE, PHARMACEUTICALS, VASCULAR BIOLOGY, COAGULATION, ANTICOAGULANTS, FIBRINOLYSIS, CYTOLOGY, CELL CULTURE, PROTEINS, PROTEIN BIOCHEMISTRY, PROTEOLYSIS, THROMBOSIS, ATHEROSCLEROSIS, AND/OR THE BIOLOGY OR TREATMENT THEREOF, PHARMACEUTICAL DRUG DEVELOPMENT, CLINICAL TRIALS, MEDICAL AND SCIENTIFIC RESEARCH, THE PREPARATION OF CHEMICALS, BIOLOGICAL PRODUCTS, FORMULATIONS AND/OR CANDIDATE PHARMACEUTICAL PRODUCTS FOR RESEARCH AND TESTING; PROMOTING PUBLIC AWARENESS FOR THE NEED FOR THROMBOSIS AND ATHEROSCLEROSIS TESTING AND TREATMENT, AND RESEARCH ON THE TESTING AND TREATMENT FOR THROMBOSIS AND ATHEROSCLEROSIS; PROVIDING REPORTS AND INFORMATION RELATING TO INTELLECTUAL PROPERTY RIGHTS | SECTION 8 - CANCELLED | — |
| 044 | MEDICAL SERVICES; MEDICAL TESTING | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by The Thrombosis Research Institute
- Other trademarks owned by The Thrombosis Research Institute
- Other trademarks in Class 016
- Other trademarks in Class 041
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named THROMBOSIS RESEARCH INSTITUTE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 21, 2012 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Aug 23, 2005 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Jul 26, 2005 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jul 13, 2005 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jul 13, 2005 | ALIE | ASSIGNED TO LIE | — |
| Jun 28, 2005 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Jun 27, 2005 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Jun 27, 2005 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 19, 2005 | CNSL | LETTER OF SUSPENSION MAILED | — |
| May 18, 2005 | CNSL | SUSPENSION LETTER WRITTEN | — |
| May 17, 2005 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| May 17, 2005 | ALIE | ASSIGNED TO LIE | — |
| Apr 25, 2005 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 25, 2005 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 1, 2004 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2004 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 31, 2004 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2004 | NWAP | NEW APPLICATION ENTERED | — |